Chlorothiazide; reserpine - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for chlorothiazide; reserpine and what is the scope of freedom to operate?
Chlorothiazide; reserpine
is the generic ingredient in five branded drugs marketed by Hikma, Watson Labs, Norvium Bioscience, and Merck, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.Summary for chlorothiazide; reserpine
| US Patents: | 0 |
| Tradenames: | 5 |
| Applicants: | 4 |
| NDAs: | 7 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| DailyMed Link: | chlorothiazide; reserpine at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for chlorothiazide; reserpine
US Patents and Regulatory Information for chlorothiazide; reserpine
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Merck | DIUPRES-500 | chlorothiazide; reserpine | TABLET;ORAL | 011635-006 | Aug 26, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hikma | CHLOROTHIAZIDE AND RESERPINE | chlorothiazide; reserpine | TABLET;ORAL | 088365-001 | Dec 22, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Norvium Bioscience | CHLOROTHIAZIDE-RESERPINE | chlorothiazide; reserpine | TABLET;ORAL | 087745-001 | May 6, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Merck | DIUPRES-250 | chlorothiazide; reserpine | TABLET;ORAL | 011635-003 | Aug 26, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Watson Labs | CHLOROTHIAZIDE W/ RESERPINE | chlorothiazide; reserpine | TABLET;ORAL | 084853-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
